SD BioSensor, Inc acquired bestbion dx - Diagnostische Produkte und Beratung GmbH for KRW 16 billion.
March 29, 2022
Share
SD BioSensor, Inc (KOSE:A137310) acquired bestbion dx - Diagnostische Produkte und Beratung GmbH for KRW 16 billion on March 30, 2022. GVG Corporate Finance Advisors acted as financial advisor to bestbion dx GmbH. Ernst & Young Global Limited acted as financial and due diligence advisor to SD BioSensor.
SD BioSensor, Inc (KOSE:A137310) completed the acquisition of bestbion dx - Diagnostische Produkte und Beratung GmbH on March 30, 2022.
SD Biosensor Inc is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets.
SD BIOSENSOR, INC 
